Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

LNTH
Lantheus Holdings, Inc
stock NASDAQ

At Close
Jul 31, 2026 3:59:58 PM EDT
99.62USD-1.361%(-1.38)1,021,907
0.00Bid   0.00Ask   0.00Spread
Pre-market
Jul 31, 2026 8:58:30 AM EDT
101.41USD+0.406%(+0.41)295
After-hours
Jul 31, 2026 4:00:30 PM EDT
99.64USD+0.015%(+0.02)174,140
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 27, 2022
08:33AM EST  Lantheus Collaborates With The Prostate Cancer Clinical Trial Consortium (PCCTC) To 'Advance AI-Enabled Imaging Biomarkers in Prostate Cancer'   Benzinga
08:30AM EST  Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus) announced that its subsidiary, EXINI Diagnostics AB (EXINI), has entered into a collaboration with the Prostate Cancer Clinical Trials Consortium (PCCTC) to advance artificial intelligence (AI)-enabled imaging biomarkers in prostate cancer.   GlobeNewswire Inc
Dec 1, 2021
08:30AM EST  Lantheus Appoints Vivian Yao as Chief Human Resources Officer   GlobeNewswire Inc
Nov 29, 2021
08:33AM EST  Lantheus Announces PYLARIFY AI Is Now Available   Benzinga
Nov 22, 2021
08:35AM EST  Lantheus Announces Centers For Medicare & Medicaid Services Grants Transitional Pass-Through Payment For PYLARIFY Injection, Effective January 1, 2022   Benzinga
08:30AM EST  PYLARIFY is the first and only commercially available, FDA-approved PSMA-targeted PET imaging agent for prostate cancer   GlobeNewswire Inc
Nov 17, 2021
08:34AM EST  Lantheus Holdings Announces Presentations Featuring PYLARIFY (Piflufolastat F 18), Its PSMA-Targeted Prostate Cancer Imaging Agent, At Key Scientific Meetings   Benzinga
08:30AM EST  Lantheus Holdings Announces Presentations Featuring   GlobeNewswire Inc
Nov 16, 2021
04:30PM EST  Lantheus Holdings to Present at the 4th Annual Evercore ISI   GlobeNewswire Inc
Nov 8, 2021
10:12AM EST  How Good Are Lantheus Holdings's Earnings? | Return On Capital Employed   Benzinga
Nov 4, 2021
08:19AM EDT  The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO   Benzinga
07:23AM EDT  Lantheus Holdings Sees Q4 2021 Revs $110M-$115M Vs $106.03M Est   Benzinga
07:16AM EDT  Lantheus Holdings Q3 Adj. EPS $0.08 Beats $0.06 Estimate, Sales $102.10M Beat $97.13M Estimate   Benzinga
07:00AM EDT  Lantheus Holdings, Inc. Reports Third Quarter 2021 Financial Results   GlobeNewswire Inc
05:00AM EDT  Earnings Scheduled For November 4, 2021   Benzinga
Oct 31, 2021
02:24PM EDT  The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline   Benzinga
Oct 21, 2021
08:00AM EDT  Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, November 4, 2021, to discuss its financial and operating results for the third quarter of 2021.   GlobeNewswire Inc
Sep 13, 2021
08:04AM EDT  Lantheus Announces Addition Of PSMA PET Imaging Agent To National Comprehensive Cancer Network (NCCN) Guidelines For Prostate Cancer   Benzinga
08:00AM EDT  Lantheus Announces Addition of PSMA PET Imaging Agent to the   GlobeNewswire Inc
07:40AM EDT  Lantheus And RefleXion Announce Development And Commercialization Collaboration To Evaluate Use Of Piflufolastat F 18   Benzinga
07:30AM EDT  Lantheus and RefleXion Announce Development and Commercialization   GlobeNewswire Inc
Sep 10, 2021
08:30AM EDT  Highlights Piflufolastat F 18s Potential to Change Initial Risk Assessment and Intended Patient Management in High-Risk Prostate Cancer   GlobeNewswire Inc
Sep 2, 2021
08:00AM EDT  Lantheus Holdings to Present at Upcoming Investor Conferences   GlobeNewswire Inc
Aug 4, 2021
11:07AM EDT  Return on Capital Employed Overview: Lantheus Holdings   Benzinga
Jul 30, 2021
08:54AM EDT  Lantheus Late Yesterday Announced The First And Only FDA Cleared AI-Enabled PSMA Digital Application, aPROMISE, Strengthening Lantheus' Leadership In Prostate Cancer   Benzinga
Jul 29, 2021
06:25PM EDT  Lantheus Announces the First and Only FDA Cleared AI-Enabled PSMA Digital Application, aPROMISE(tm), Strengthening Lantheus' Leadership in Prostate Cancer   Business Wire
05:44AM EDT  SVB Leerink Maintains Outperform on Lantheus Holdings, Raises Price Target to $34   Benzinga
Jul 28, 2021
10:04AM EDT  Lantheus Stock Gains As Q2 Earnings Surpasses Expectations; Raises FY2021 Outlook   Benzinga
07:38AM EDT  Lantheus Holdings Q2 GAAP Net Loss $26.7 Mln Or $0.39/shr Vs. Net Loss $7.0 Mln Or $0.16/shr Last Year   RTTNews
07:33AM EDT  The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal   Benzinga
07:30AM EDT  Lantheus Holdings: Q2 Earnings Insights   Benzinga
07:12AM EDT  Lantheus Sees Q3 Adj. EPS $0.05-$0.07 vs $0.12 Est., Sales $95M-$100M vs $102.83M Est.; Raises FY21 Adj. EPS $0.36-$0.41 vs $0.38 Est., Raises Sales Guidance From $390M-$400M To $395M-$402M vs $396.38M Est.   Benzinga
07:09AM EDT  Lantheus Holdings Q2 Adj. EPS $0.11 Beats $0.05 Estimate, Sales $101.10M Beat $94.87M Estimate   Benzinga
07:00AM EDT  Lantheus Holdings, Inc. Reports Second Quarter 2021 Financial Results   Business Wire
04:27AM EDT  Earnings Scheduled For July 28, 2021   Benzinga
Jul 27, 2021
11:13AM EDT  Earnings Preview: Lantheus Holdings   Benzinga
Jul 25, 2021
10:05AM EDT  The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More   Benzinga
Jul 14, 2021
08:00AM EDT  Lantheus Holdings to Host Second Quarter 2021 Earnings Conference Call and Webcast on July 28, 2021 at 8:00 a.m. Eastern Time   Business Wire
Jul 2, 2021
07:38AM EDT  The Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures   Benzinga
Jun 30, 2021
07:29AM EDT  The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs   Benzinga
Jun 25, 2021
07:32AM EDT  The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs   Benzinga
Jun 24, 2021
08:12AM EDT  The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO   Benzinga
Jun 14, 2021
08:34AM EDT  Lantheus To Present Piflufolastat F 18 Data At Virtual Society Of Nuclear Medicine And Molecular Imaging 2021 Annual Meeting   Benzinga
08:30AM EDT  Lantheus To Present Piflufolastat F 18 Data at the Virtual Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2021 Annual Meeting   Business Wire
Jun 3, 2021
08:23AM EDT  The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune's Readout   Benzinga
Jun 2, 2021
10:38AM EDT  Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates   Benzinga
08:20AM EDT  The Daily Biotech Pulse: FDA Nod For Novartis, iRhythm CEO Quits Abruptly, Moderna Inks Vaccine Supply Agreements   Benzinga
Jun 1, 2021
05:31PM EDT  Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates   Benzinga
May 27, 2021
08:54AM EDT  Lantheus Shares Trading Higher On FDA Approval For Imaging Agent For Identification Of Prostate Cancer   Benzinga
08:24AM EDT  The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs   Benzinga
07:12AM EDT  Lantheus Gets FDA Approval Of PYLARIFY Injection   RTTNews
07:04AM EDT  Lantheus Receives US FDA Approval Of PYLARIFY Injection   Benzinga
07:00AM EDT  Lantheus Receives U.S. FDA Approval of PYLARIFY(r) (piflufolastat F 18) Injection, the First and Only Commercially Available PSMA PET Imaging Agent for Prostate Cancer   Business Wire
May 23, 2021
10:06AM EDT  The Week Ahead In Biotech (May 23-29): Eton, Lantheus FDA Decisions, Adcom Test For Provention, Chiasma Data Presentation   Benzinga
May 21, 2021
08:31AM EDT  Lantheus Holdings Highlights Presentation Featuring F-DCFPyL PET/CT, its PSMA-Targeted Prostate Cancer Imaging Agent at the 2021 ASCO Annual Meeting Jun. 4-8, 2021   Benzinga
08:30AM EDT  Lantheus Holdings Announces Presentation Featuring 18F-DCFPyL PET/CT, its PSMA-Targeted Prostate Cancer Imaging Agent at the 2021 ASCO Annual Meeting   Business Wire
May 20, 2021
08:30AM EDT  Lantheus Holdings to Present at the Jefferies Virtual Healthcare Conference   Business Wire
May 5, 2021
10:13AM EDT  Credit Suisse Maintains Neutral on Lantheus Holdings, Raises Price Target to $20   Benzinga
07:43AM EDT  The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues   Benzinga
May 4, 2021
08:10AM EDT  The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data   Benzinga
07:38AM EDT  Lantheus Sees Q2 Sales $93M-$97M vs $93.25M Estimate, Adj. EPS $0.03-$0.06 vs $0.04 Est.; Narrows FY21 Sales Guidance From $385M-$400M To $390M-$400M vs $390.6M Est., Raises Adj. EPS Guidance From $0.34-$0.39 To $0.36-$0.41 vs $0.37 Est.   Benzinga
07:32AM EDT  Lantheus Holdings Q1 Net Income $9.0 Mln Vs. $3.3 Mln Last Year   RTTNews
07:28AM EDT  Lantheus Holdings Q1 EPS $0.05 Beats $(0.01) Estimate, Sales $92.51M Beat $87.24M Estimate   Benzinga
07:26AM EDT  Lantheus Holdings: Q1 Earnings Insights   Benzinga
07:00AM EDT  Lantheus Holdings, Inc. Reports First Quarter 2021 Financial Results   Business Wire
May 3, 2021
08:43AM EDT  EXINI Diagnostics AB, a Lantheus Company, Receives CE Mark Clearance for aPROMISE in Europe   Benzinga
Apr 30, 2021
08:37AM EDT  Lantheus Holdings Announces Strategic Collaboration With Allegheny Health Network   RTTNews
08:32AM EDT  Lantheus Grants Allegheny Health Network Exclusive Rights For Use Of Its Microbubbles In Combination With Ultrasound Assisted Gene Therapy For Development Of Proposed Treatment for Xerostomia   Benzinga
08:30AM EDT  Lantheus Grants Allegheny Health Network Exclusive Rights for the Use of its Microbubbles in Combination with Ultrasound Assisted Gene Therapy for the Development of a Proposed Treatment for Xerostomia   Business Wire
07:31AM EDT  The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs   Benzinga
Apr 29, 2021
08:15AM EDT  The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx   Benzinga
Apr 28, 2021
07:26AM EDT  The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping   Benzinga
07:12AM EDT  SVB Leerink Maintains Outperform on Lantheus Holdings, Raises Price Target to $31   Benzinga
Apr 27, 2021
07:41AM EDT  The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout   Benzinga
Apr 23, 2021
07:28AM EDT  The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs   Benzinga
Apr 20, 2021
08:30AM EDT  Lantheus Holdings to Host First Quarter 2021 Earnings Conference Call and Webcast on May 4, 2021 at 8:00 a.m. Eastern Time   Business Wire
Apr 7, 2021
08:30AM EDT  Lantheus Expands R&D Leadership Team with Key New Hires   Business Wire
Apr 1, 2021
08:34AM EDT  Lantheus Announces Retirement Of Michael Duffy, SVP And General Counsel   RTTNews
08:30AM EDT  Lantheus Announces Retirement of Michael P. Duffy, Senior Vice President and General Counsel   Business Wire
Mar 30, 2021
12:51PM EDT  Novartis Beefs Up Radioligand Portfolio With iTheranostics Deal   Benzinga
12:45PM EDT  Lantheus Buys Rights To Fibroblast Activation Protein Targeting Imaging Biomarker   Benzinga
08:34AM EDT  Lantheus Acquires Exclusive, Worldwide Rights To Develop, manufacture And Commercialize NTI-1309   RTTNews
08:31AM EDT  Lantheus Acquires Rights To Develop, Manufacture And Commercialize NTI-1309; Financial Details Not Disclosed   Benzinga
08:29AM EDT  Lantheus Acquires Rights to Innovative Imaging Biomarker Targeting Fibroblast Activation Protein (FAP) from Noria   Business Wire
Mar 22, 2021
08:41AM EDT  Lantheus Presents Updated Biochemical Tumor Marker Data From Its Pivotal Phase 2 Trial Of AZEDRA   RTTNews
08:35AM EDT  Lantheus Announces Presentation Featuring AZEDRA (Iobenguane | 131) At ENDO 2021   Benzinga
Mar 1, 2021
08:46AM EST  Lantheus Announces Publication Of PyL Results From Pivotal Studies In Journal Of Urology And Clinical Cancer Research; Journal Of Urology Says Primary Endpoint For Specificity Was Met While Primary Endpoint For Sensitivity Was Not   Benzinga
08:30AM EST  Lantheus Announces Publication of PyL(tm) (18F-DCFPyL) Results from Pivotal Studies   Business Wire
Feb 26, 2021
09:05AM EST  Credit Suisse Maintains Neutral on Lantheus Holdings, Raises Price Target to $17   Benzinga
05:24AM EST  SVB Leerink Maintains Outperform on Lantheus Holdings, Raises Price Target to $25   Benzinga
Feb 25, 2021
04:41PM EST  Recap: Lantheus Holdings Q4 Earnings   Benzinga
04:27PM EST  Lantheus Holdings Sees FY21 EPS $0.34-$0.39 Vs. $0.42 Est., Sales $385M-$400M Vs. $408.64M Est.   Benzinga
04:26PM EST  Lantheus Holdings Sees Q1 EPS $(0.03)-$0.00 Vs. $0.02 Est., Sales $85M-$89M Vs. $98.07M Est.   Benzinga
04:25PM EST  Lantheus Holdings Q4 EPS $0.07 Beats $0.01 Estimate, Sales $94.15M Beat $92.23M Estimate   Benzinga
04:02PM EST  Lantheus Reports Fourth Quarter and Full Year 2020 Financial Results   Business Wire
08:08AM EST  The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants   Benzinga
04:03AM EST  Earnings Scheduled For February 25, 2021   Benzinga
Feb 12, 2021
08:30AM EST  Lantheus Holdings to Present at the 10th Annual SVB Leerink Global Healthcare Conference   Business Wire
Feb 11, 2021
04:30PM EST  Lantheus Holdings to Host Fourth Quarter and Full Year 2020 Earnings Conference Call and Webcast on February 25, 2020 at 4:30 p.m. Eastern Time   Business Wire
11:21AM EST  Stocks That Hit 52-Week Highs On Thursday   Benzinga
Feb 4, 2021
08:30AM EST  Lantheus Holdings Announces Presentations Featuring its PSMA-Targeted Pipeline Product Candidates at the 2021 ASCO GU Annual Meeting   Business Wire
Feb 1, 2021
10:03AM EST  Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2021   Benzinga
Jan 12, 2021
08:39AM EST  Lantheus Holdings Reports Submission Of Drug Master File For NM-01 In U.S.   RTTNews
08:38AM EST  Lantheus Holdings Announces Submission Of Drug Master File For NM-01 In US   Benzinga
08:30AM EST  Lantheus Holdings Announces Submission of Drug Master File for NM-01 in the U.S.   Business Wire
Dec 29, 2020
09:11AM EST  7 Biggest Price Target Changes For Tuesday   Benzinga
08:39AM EST  Credit Suisse Maintains Neutral on Lantheus Holdings, Lowers Price Target to $14   Benzinga
Dec 9, 2020
02:22PM EST  Lantheus Holdings Announces Acceptance, Priority Review Of New Drug Application For PyLTM   Benzinga
02:19PM EST  Lantheus Holdings Announces Acceptance and Priority Review of New Drug Application for PyLTM (18F-DCFPyL), a PSMA-Targeted Prostate Cancer PET Imaging Agent   Business Wire
08:50AM EST  Lantheus, Progenics In Deal With POINT Biopharma To Use Lantheus' Investigational PSMA-targeted PET Imaging Agent   RTTNews
08:37AM EST  Lantheus Holdings Announces Collaboration With POINT BiopharmaTo Use Lantheus' PSMA-Targeted Prostate Cancer Imaging Agent In PSMA-Targeted Radioligand Therapeutic Phase 3 Trial In Patients With Metastatic Castration Resistant Prostate Cancer   Benzinga
08:30AM EST  PyL(tm) (18F-DCFPyL), Lantheus' PSMA-Targeted Prostate Cancer Imaging Agent, to be Used in POINT Biopharma's PSMA-Targeted Radioligand Therapeutic Phase 3 Trial in Patients with Metastatic Castration Resistant Prostate Cancer   Business Wire
Dec 3, 2020
07:23AM EST  Lantheus Holdings Agrees To Sell Puerto Rico Radiopharmacy And PET Manufacturing Facility   RTTNews
07:00AM EST  Lantheus Holdings, Inc. Announces Agreement to Sell Its Puerto Rico Radiopharmacy and PET Manufacturing Facility and Enter into Long-Term Supply Agreement   Business Wire
Nov 24, 2020
08:00AM EST  Lantheus Holdings to Present at the 2020 Evercore ISI HealthCONx Conference   Business Wire
Nov 19, 2020
08:17AM EST  The Daily Biotech Pulse: Aquestive's Positive FDA Meeting, Prevail Awarded Patent, Neuro-Oncology Conference Gets Underway   Benzinga
Nov 18, 2020
06:18PM EST  After-Hours Market: Nuance, Sonos, Aquestive, Lantheus   RTTNews
04:01PM EST  Lantheus Holdings, Inc. Announces FDA Approval of DEFINITY Room Temperature   Benzinga
Nov 13, 2020
08:34AM EST  Lantheus Reports FDA Clearance For AI-Enabled ABSI In Prostate Cancer On GE Healthcare's Xeleris Platform   RTTNews
08:30AM EST  Lantheus Holdings Announces FDA Clearance For AI-Enabled Automated Bone Scan Index (aBSI) In Prostate Cancer On GE Healthcare's Xeleris Platform   Benzinga
Nov 9, 2020
04:30PM EST  CORRECTION: TIME CHANGE - Lantheus Holdings to Present at November 2020 Investor Conferences   Business Wire
Nov 5, 2020
07:22AM EST  Lantheus Holdings Q3 EPS $0.04 Beats $0.01 Estimate, Sales $88.50M Miss $90.44M Estimate   Benzinga
07:00AM EST  Lantheus Holdings, Inc. Reports Third Quarter 2020 Financial Results   Business Wire
04:34AM EST  Earnings Scheduled For November 5, 2020   Benzinga
Nov 4, 2020
08:00AM EST  Lantheus Holdings to Present at November 2020 Investor Conferences   Business Wire
Nov 2, 2020
08:59AM EST  Morgan Stanley Maintains Equal-Weight on Rocket Companies, Lowers Price Target to $23   Benzinga
Oct 29, 2020
08:55AM EDT  Lantheus Enters Into Strategic Collaboration With Insightec For Use Of Microbubbles In Combination With MR-Guided Focused Ultrasound For Treatment Of Glioblastoma And Neurodegenerative Conditions   Benzinga
Oct 22, 2020
07:30AM EDT  Lantheus Holdings to Host Third Quarter 2020 Earnings Conference Call and Webcast on November 5, 2020 at 8:00 a.m. Eastern Time   Business Wire
Oct 8, 2020
08:26AM EDT  Lantheus Holdings Announces Presentations At 33rd Annual European Association Of Nuclear Medicine Virtual Congress Oct. 22-23   Benzinga
08:25AM EDT  Lantheus Holdings Announces Presentations at the 33rd Annual European Association of Nuclear Medicine (EANM) Virtual Congress   Business Wire
Sep 30, 2020
08:07AM EDT  Lantheus Holdings Submits NDA To FDA For PyL, A PSMA-Targeted Prostate Cancer Imaging Agent   RTTNews
08:05AM EDT  Lantheus Holdings Submits New Drug Application to the U.S. FDA for PyL, a PSMA-Targeted Prostate Cancer Imaging Agent   Benzinga
08:00AM EDT  Lantheus Holdings Submits New Drug Application to the U.S. FDA for PyL(tm) (18F-DCFPyL), a PSMA-Targeted Prostate Cancer Imaging Agent   Business Wire
Sep 3, 2020
08:00AM EDT  Lantheus Holdings to Present at the Wells Fargo 2020 Virtual Healthcare Conference   Business Wire
Aug 12, 2020
10:48AM EDT  Lantheus shares are trading higher after the company announced that the FDA approved its VIALMIX RFID Device for DIGNITY.   Benzinga
08:09AM EDT  Lantheus Holdings: FDA Approves SNDA For VIALMIX RFID For DEFINITY   RTTNews
08:02AM EDT  Lantheus Holdings, Inc. Announces FDA Approval Of VIALMIX RFID Device For DEFINITY   Benzinga
08:00AM EDT  Lantheus Holdings, Inc. Announces FDA Approval of VIALMIX(r) RFID Device for DEFINITY(r)   Business Wire
Jul 30, 2020
07:07AM EDT  Lantheus Holdings Q2 EPS $0.10 Beats $0.05 Estimate, Sales $66.00M Beat $56.62M Estimate   Benzinga
07:00AM EDT  Lantheus Holdings, Inc. Reports Second Quarter 2020 Financial Results   Business Wire
04:06AM EDT  Earnings Scheduled For July 30, 2020   Benzinga
Jul 23, 2020
08:00AM EDT  Lantheus Holdings to Host Second Quarter 2020 Earnings Conference Call on July 30, 2020 at 8:00 a.m. Eastern Time   Business Wire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC